Kepos Capital LP Gilead Sciences, Inc. Transaction History

Kepos Capital LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $991,746 - $1.27 Million	-15,835 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $3,882 - $4,270	-63 Reduced 0.4%	15,835 $1.03 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $993,783 - $1.1 Million	15,898 New	15,898 $1.01 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $6.57 Million - $7.36 Million	-105,041 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $1.86 Million - $2.42 Million	30,650 Added 41.2%	105,041 $6.57 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $5.3 Million - $5.87 Million	74,391 New	74,391 $5.74 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $3.63 Million - $4.23 Million	-55,946 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $698,462 - $851,503	-9,589 Reduced 14.63%	55,946 $4.22 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $1.85 Million - $2.17 Million	26,041 Added 65.94%	65,535 $4.7 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $2.85 Million - $3.38 Million	39,494	39,494 $3.2 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.